New Delhi: With coronavirus cases rising in the country, Serum Institute of India (SII) has written to the Union Health ministry seeking the inclusion of its COVID-19 vaccine Covovax on the CoWIN portal as a heterologous booster for adults.
SII Director Prakash Kumar Singh wrote the letter last week, PTI reported quoting officials.
COVID-19 Working Group, headed by Dr NK Arora, had last month recommended the inclusion of Covovax on CoWIN portal as a booster for adults who have received two doses of either Covishield or Covaxin.
India reported 3,641 fresh COVID-positive cases on Monday.
On January 16, Drugs Controller General of India (DCGI) approved the necessary market authorisation for Covovax as a heterologous booster.
Covovax has already been approved by World Health Organisation (WHO) and US Food and Drug Administration (USFDA).
Covovax is manufactured by SII through technology transfer from US-based vaccine maker Novavax.
Mumbai: Ananya Panday and Aditya Roy Kapur were one of the most talked-about couples of…
Balangir: Former MLA Jagneswar Babu, who left Congress recently, joined Bharatiya Janata Party in Odisha's…
Ayodhya: Prime Minister Narendra Modi held a grand roadshow here on Sunday evening after offering…
Puri: Congress' candidate for Puri Sadar Assembly constituency in Odisha Uma Ballav Rath was allegedly…
Bhubaneswar: A total of 115 boys and girls from Nepal, Canada, USA and host country…
New Delhi: Kishori Lal Sharma, Congress’ surprise choice for Amethi Lok Sabha constituency, said on…
Puri: The under-production Odia film 'Ashram' will be released in cinema theatres across Odisha in…
New Delhi: The Council for the Indian School Certificate Examinations (CISCE) will announce results for…